Cosine
VC Fund
New York, United States
Cosine is a VC fund in New York focused on Video and Education. A New York based biotech investment company.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cosine invests in
Stages Cosine invests in
Countries Cosine invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Gillian Sandler
|
|||
Investment Focus
Industry
- Video 1 (33%)
- Education 1 (33%)
- Therapeutics 1 (33%)
- Biotechnology 1 (33%)
- Bioinformatics 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Convertible Note 1 (33%)
Country
- South Korea 1 (33%)
- United States 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gillian Sandler
Team Member
|
Team Member | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Geekble
|
Geekble is a media startup that produces new media content on science and technology to bridge the gap between geeks and the world. With revenue from workshops and branded content, Geekble is building its own "maker space" for geeks to experiment. Teachers and professors are using Geekble's content for educational purposes, andGeekble videos have been used for public TV. | $3.7M / Convertible Note / Jul 18, 2022 | |
|
Geekble
|
Geekble is a media startup that produces new media content on science and technology to bridge the gap between geeks and the world. With revenue from workshops and branded content, Geekble is building its own "maker space" for geeks to experiment. Teachers and professors are using Geekble's content for educational purposes, andGeekble videos have been used for public TV. | $3.8M / Series A / Jul 18, 2022 | |
Envisagenics
|
Envisagenics focus on the discovery of RNA therapeutics. Their mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused bymutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered.Their breakthrough technology, SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence. We are using our software to identify splicing errors causative of diseases, identify the right drug targets, and develop RNA therapeutics through partnerships and collaborations with Biopharma. Their in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs.Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. | $2.4M / Seed / Nov 28, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cosine invest in?
Cosine invests primarily in Video, Education and Therapeutics startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cosine?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cosine?
The team at Cosine includes Gillian Sandler (Team Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
